VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1601616
Sex: F
Age: 59
State: NJ

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Painful; looks like Covid Arm, hot to touch, and painful; Injection site is a bright red mark; had terrible Chills; Fever went 103 degrees Farenheight; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (looks like Covid Arm, hot to touch, and painful), VACCINATION SITE ERYTHEMA (Injection site is a bright red mark), VACCINATION SITE PAIN (Painful), CHILLS (had terrible Chills) and PYREXIA (Fever went 103 degrees Farenheight) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced CHILLS (had terrible Chills) and PYREXIA (Fever went 103 degrees Farenheight). On 30-Mar-2021, the patient experienced VACCINATION SITE WARMTH (looks like Covid Arm, hot to touch, and painful) and VACCINATION SITE ERYTHEMA (Injection site is a bright red mark). On an unknown date, the patient experienced VACCINATION SITE PAIN (Painful). On 29-Mar-2021, PYREXIA (Fever went 103 degrees Farenheight) had resolved. At the time of the report, VACCINATION SITE WARMTH (looks like Covid Arm, hot to touch, and painful), VACCINATION SITE ERYTHEMA (Injection site is a bright red mark), VACCINATION SITE PAIN (Painful) and CHILLS (had terrible Chills) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Mar-2021, Body temperature: 103 degrees farenheight (High) 103 degrees Farenheight. Treatment for the events included Prednisone and Antibiotics. Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. This case was linked to MOD-2021-079925 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1601617
Sex: M
Age: 19
State: WA

Vax Date: 03/04/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm on his injection site arm), PYREXIA (Fever of 101.4 Degrees Farenheight), CHILLS (Chills) and MYALGIA (Muscle aches) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (Np medical history reported.). On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore arm on his injection site arm), PYREXIA (Fever of 101.4 Degrees Farenheight), CHILLS (Chills) and MYALGIA (Muscle aches). At the time of the report, VACCINATION SITE PAIN (Sore arm on his injection site arm), PYREXIA (Fever of 101.4 Degrees Farenheight), CHILLS (Chills) and MYALGIA (Muscle aches) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment medication was not provided.

Other Meds:

Current Illness:

ID: 1601618
Sex: F
Age: 57
State: MI

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain on the right leg; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain on the right leg) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included AMLODIPINE, POTASSIUM, COLECALCIFEROL (VITAMIN D 3) and CHLORTHALIDONE for an unknown indication. On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain on the right leg). At the time of the report, PAIN IN EXTREMITY (pain on the right leg) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information included Tylenol and ibuprofen.

Other Meds: AMLODIPINE; POTASSIUM; VITAMIN D 3; CHLORTHALIDONE

Current Illness:

ID: 1601619
Sex: F
Age: 52
State: NC

Vax Date: 03/27/2021
Onset Date: 03/30/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: leg pain; Back pain; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (leg pain) and BACK PAIN (Back pain) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (leg pain) and BACK PAIN (Back pain). The patient was treated with TIZANIDINE at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (leg pain) and BACK PAIN (Back pain) outcome was unknown. Not Provided Action taken with mRNA-1273 in response to the event was not applicable. Many concomitant drugs were used which was not reported. Treatment for the event included prednisone which was substituted by Tizanidine.

Other Meds:

Current Illness:

ID: 1601620
Sex: F
Age: 88
State: NC

Vax Date: 02/12/2021
Onset Date: 03/19/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Mar-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (pain in arm). At the time of the report, PAIN IN EXTREMITY (pain in arm) outcome was unknown. Not Provided This case was linked to MOD-2021-064163.; Sender's Comments: MOD-2021-064163:first dose

Other Meds:

Current Illness:

ID: 1601621
Sex: M
Age: 66
State:

Vax Date: 02/17/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I haven't taken my 2nd dose yet because google and some websites and the facility where I got; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-Mar-2021 and was forwarded to Moderna on 23-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I haven't taken my 2nd dose yet because google and some websites and the facility where I got) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I haven't taken my 2nd dose yet because google and some websites and the facility where I got). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I haven't taken my 2nd dose yet because google and some websites and the facility where I got) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1601622
Sex: M
Age:
State: TN

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: using his oxygen during the day as well at night/been going down to 90 without it, with it goes back up to his normal 93; This spontaneous case was reported by a patient and describes the occurrence of OXYGEN SATURATION DECREASED (using his oxygen during the day as well at night/been going down to 90 without it, with it goes back up to his normal 93) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013a21a) for COVID-19 vaccination. Concurrent medical conditions included COPD, Arrhythmia and Diabetes mellitus. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced OXYGEN SATURATION DECREASED (using his oxygen during the day as well at night/been going down to 90 without it, with it goes back up to his normal 93). At the time of the report, OXYGEN SATURATION DECREASED (using his oxygen during the day as well at night/been going down to 90 without it, with it goes back up to his normal 93) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Patients due date for second dose was on 02 apr 2021 This case was linked to US-MODERNATX, INC.-MOD-2021-063946 (E2B Linked Report). Reporter did not allow further contact

Other Meds:

Current Illness: Arrhythmia; COPD; Diabetes mellitus

ID: 1601623
Sex: F
Age: 72
State: MI

Vax Date: 03/02/2021
Onset Date: 03/30/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and PAIN IN EXTREMITY (Sore arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 047A21A) for COVID-19 vaccination. No medical history was provided by the reporter. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced PYREXIA (fever) and PAIN IN EXTREMITY (Sore arm). At the time of the report, PYREXIA (fever) and PAIN IN EXTREMITY (Sore arm) had not resolved. Not Provided Treatment details were not provided.

Other Meds:

Current Illness:

ID: 1601624
Sex: M
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: The amount was less than 1/2 of the administered dose; This spontaneous case was reported by a health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (The amount was less than 1/2 of the administered dose) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (The amount was less than 1/2 of the administered dose). At the time of the report, ACCIDENTAL UNDERDOSE (The amount was less than 1/2 of the administered dose) had resolved. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant product use was reported No treatment information was provided Action taken with mRNA-1273 was not applicable

Other Meds:

Current Illness:

ID: 1601625
Sex: F
Age: 61
State: NY

Vax Date: 03/16/2021
Onset Date: 03/16/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Minimal Pain at the Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Minimal Pain at the Injection Site) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. No Medical History information was reported. On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE PAIN (Minimal Pain at the Injection Site). On 17-Mar-2021, VACCINATION SITE PAIN (Minimal Pain at the Injection Site) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported. No treatment reported.

Other Meds:

Current Illness:

ID: 1601626
Sex: M
Age: 60
State: FL

Vax Date: 03/15/2021
Onset Date: 03/15/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: indentation at the injection site 3 inches long to a quarter inch deep; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE INDENTATION (indentation at the injection site 3 inches long to a quarter inch deep) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 017B21A) for COVID-19 vaccination. The patient's past medical history included Melanoma in 2016 and Skin neoplasm excision (melanoma removal) in 2016. Concurrent medical conditions included Penicillin allergy, Sumac rash, Drug allergy and Allergy to antibiotic. On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced INJECTION SITE INDENTATION (indentation at the injection site 3 inches long to a quarter inch deep). At the time of the report, INJECTION SITE INDENTATION (indentation at the injection site 3 inches long to a quarter inch deep) had not resolved. No concomitant medications were reported. Treatment information was not reported Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Follow up received on 17-MAY-2021 and Patient Race ,ethnic group ,Allergies were updated and second dose was updated On 25-Jul-2021: Follow-up received on 25-Jul-2021 and does not contain any new information. Patient reported no change.

Other Meds:

Current Illness: Allergy to antibiotic; Drug allergy; Penicillin allergy; Sumac rash

ID: 1601627
Sex: F
Age: 79
State: FL

Vax Date: 02/14/2021
Onset Date: 03/31/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in the bones; A sore throat; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Pain in the bones) and OROPHARYNGEAL PAIN (A sore throat) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 007M20A) for COVID-19 vaccination. No Medical History information was reported. On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced BONE PAIN (Pain in the bones) and OROPHARYNGEAL PAIN (A sore throat). At the time of the report, BONE PAIN (Pain in the bones) and OROPHARYNGEAL PAIN (A sore throat) outcome was unknown. Not Provided No concomitant medications were provided. Treatment medications were unknown. Action taken with mRNA-1273 in response to the events was not applicable. The patient has already received both doses and wants to know if she can get the vaccine again in 6 months.

Other Meds:

Current Illness:

ID: 1601628
Sex: F
Age: 83
State: GA

Vax Date: 03/05/2021
Onset Date: 03/05/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dizziness that comes and goes; Vaccination site discomfort; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (Vaccination site discomfort) and DIZZINESS (dizziness that comes and goes) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02A21A) for COVID-19 vaccination. No Medical History information was reported. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE DISCOMFORT (Vaccination site discomfort). On 25-Mar-2021, the patient experienced DIZZINESS (dizziness that comes and goes). The patient was treated with DIMENHYDRINATE (DRAMAMINE) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE DISCOMFORT (Vaccination site discomfort) and DIZZINESS (dizziness that comes and goes) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter Treatment information was not provided

Other Meds:

Current Illness:

ID: 1601629
Sex: F
Age: 50
State: FL

Vax Date: 03/19/2021
Onset Date: 03/30/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore throat(Cannot swallow food); Dizziness (Has trouble staying awake); fever(Temperature 101F); nausea; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat(Cannot swallow food)), DIZZINESS (Dizziness (Has trouble staying awake)), PYREXIA (fever(Temperature 101F)) and NAUSEA (nausea) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K21A and 047A21A) for COVID-19 vaccination. Co-suspect product included non-company product HEPATITIS E VACCINE for an unknown indication. No medical history was reported. Concomitant products included CARVEDILOL, ROSUVASTATIN, HYDROCORTISONE, OXYCODONE, TIZANIDINE HYDROCHLORIDE (ZANAFLEX), DIAZEPAM (VALIUM), ZOLPIDEM TARTRATE (AMBIEN), CYANOCOBALAMIN (VITAMIN B12 AAA), VITAMIN D3 and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication. On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient started HEPATITIS E VACCINE (unknown route) at an unspecified dose. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat(Cannot swallow food)), DIZZINESS (Dizziness (Has trouble staying awake)), PYREXIA (fever(Temperature 101F)) and NAUSEA (nausea). At the time of the report, OROPHARYNGEAL PAIN (sore throat(Cannot swallow food)), DIZZINESS (Dizziness (Has trouble staying awake)), PYREXIA (fever(Temperature 101F)) and NAUSEA (nausea) outcome was unknown. Treatment information was not provided. On 30 MAR 2021 within 11 days of receiving the COVID-19 second dose). A few hours after receiving the hepatitis vaccine (patient does not know whether it was hepatitis B or Hepatitis A vaccine) experienced the events.

Other Meds: CARVEDILOL; ROSUVASTATIN; HYDROCORTISONE; OXYCODONE; ZANAFLEX; VALIUM; AMBIEN; VITAMIN B12 AAA; VITAMIN D3; ASPIRIN (E.C.)

Current Illness:

ID: 1601630
Sex: U
Age:
State:

Vax Date: 02/05/2021
Onset Date: 02/05/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Breast-Feeding; Pain in the arm of the injection; Shortness of breath; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm of the injection), DYSPNOEA (Shortness of breath) and MATERNAL EXPOSURE DURING BREAST FEEDING (Breast-Feeding) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in the arm of the injection) and DYSPNOEA (Shortness of breath). On an unknown date, the patient experienced MATERNAL EXPOSURE DURING BREAST FEEDING (Breast-Feeding). At the time of the report, PAIN IN EXTREMITY (Pain in the arm of the injection) and DYSPNOEA (Shortness of breath) outcome was unknown and MATERNAL EXPOSURE DURING BREAST FEEDING (Breast-Feeding) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications and treatment details were not reported.

Other Meds:

Current Illness:

ID: 1601631
Sex: F
Age:
State: TX

Vax Date: 03/10/2021
Onset Date: 03/10/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 4 days later, she fell and hurt herself; she had a big bruise on right leg; She had open cut on her right leg; term 4 days later, she fell and hurt herself; She had a sore arm after receiving 2nd dose; She had little fever; This spontaneous case was reported by a consumer and describes the occurrence of FALL (4 days later, she fell and hurt herself), CONTUSION (she had a big bruise on right leg), WOUND (She had open cut on her right leg), PAIN (term 4 days later, she fell and hurt herself) and PAIN IN EXTREMITY (She had a sore arm after receiving 2nd dose) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (She had a sore arm after receiving 2nd dose) and PYREXIA (She had little fever). On 14-Mar-2021, the patient experienced FALL (4 days later, she fell and hurt herself), CONTUSION (she had a big bruise on right leg), WOUND (She had open cut on her right leg) and PAIN (term 4 days later, she fell and hurt herself). At the time of the report, FALL (4 days later, she fell and hurt herself), CONTUSION (she had a big bruise on right leg), WOUND (She had open cut on her right leg), PAIN (term 4 days later, she fell and hurt herself), PAIN IN EXTREMITY (She had a sore arm after receiving 2nd dose) and PYREXIA (She had little fever) outcome was unknown. No concomitant medication reported No treatment medication reported Action taken with mRNA-1273 was not applicable

Other Meds:

Current Illness:

ID: 1601632
Sex: F
Age: 39
State: NY

Vax Date: 03/17/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore throat; felt "crummy".; delayed reaction of hot spots around the injection site; red injection site; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), MALAISE (felt "crummy".), VACCINATION SITE WARMTH (delayed reaction of hot spots around the injection site) and VACCINATION SITE ERYTHEMA (red injection site) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination. No Medical History information was reported. On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore throat), MALAISE (felt "crummy".), VACCINATION SITE WARMTH (delayed reaction of hot spots around the injection site) and VACCINATION SITE ERYTHEMA (red injection site). The patient was treated with IBUPROFEN at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (sore throat), MALAISE (felt "crummy".), VACCINATION SITE WARMTH (delayed reaction of hot spots around the injection site) and VACCINATION SITE ERYTHEMA (red injection site) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant product use was reported

Other Meds:

Current Illness:

ID: 1601633
Sex: M
Age: 77
State: VA

Vax Date: 03/17/2021
Onset Date: 03/01/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Confusion; Very sore arm; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Confusion) and PAIN IN EXTREMITY (Very sore arm) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. No Medical History information was reported. On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced CONFUSIONAL STATE (Confusion) and PAIN IN EXTREMITY (Very sore arm). At the time of the report, CONFUSIONAL STATE (Confusion) and PAIN IN EXTREMITY (Very sore arm) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment medications were reported.

Other Meds:

Current Illness:

ID: 1601634
Sex: F
Age: 74
State: TX

Vax Date: 02/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: (2nd dose) soreness at the injection site; (2nd dose) trouble sleeping; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN ((2nd dose) soreness at the injection site) and INSOMNIA ((2nd dose) trouble sleeping) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 027A21A) for COVID-19 vaccination. Previously administered products included for an unreported indication: COVID-19 VACCINE (Sore arm after first shot of covid-19 vaccine that resolved in two days) on 02-Feb-2021. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced INJECTION SITE PAIN ((2nd dose) soreness at the injection site) and INSOMNIA ((2nd dose) trouble sleeping). At the time of the report, INJECTION SITE PAIN ((2nd dose) soreness at the injection site) and INSOMNIA ((2nd dose) trouble sleeping) outcome was unknown. medication for diabetes was taken concomitantly by the patient No treatment information was provided Action taken with mRNA-1273 Moderna COVID-19 Vaccine was not applicable

Other Meds:

Current Illness:

ID: 1601635
Sex: F
Age:
State: MA

Vax Date: 02/03/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: (injection site) very mild arm pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN ((injection site) very mild arm pain) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 010A21A) for Immunisation. The patient's past medical history included No adverse event. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2. On an unknown date, the patient experienced VACCINATION SITE PAIN ((injection site) very mild arm pain). This case was linked to US-MODERNATX, INC.-MOD-2021-016319 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-016319:Linked with first dose case

Other Meds:

Current Illness:

ID: 1601636
Sex: U
Age:
State: LA

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 16 year old twins received Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old twins received Moderna vaccine) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old twins received Moderna vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old twins received Moderna vaccine) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2021-067052 (Patient Link).; Sender's Comments: This report refers to a case of Product administered to patient of inappropriate age for mRNA-1273, lot # unknown, with no associated AEs.

Other Meds:

Current Illness:

ID: 1601637
Sex: M
Age: 61
State: MA

Vax Date: 03/12/2021
Onset Date: 03/28/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and FATIGUE (Fatigue) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. No Medical History information was reported. On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced CHILLS (Chills) and FATIGUE (Fatigue). On 30-Mar-2021, CHILLS (Chills) and FATIGUE (Fatigue) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication reported by the reporter No treatment reported by the reporter

Other Meds:

Current Illness:

ID: 1601638
Sex: F
Age:
State: FL

Vax Date: 02/25/2021
Onset Date: 03/01/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hot to the touch; itchy; it started hurting and it was a litlte red; It is red; hernia surgery after first dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HERNIA REPAIR (hernia surgery after first dose), VACCINATION SITE WARMTH (hot to the touch), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE PAIN (it started hurting and it was a litlte red) and VACCINATION SITE ERYTHEMA (It is red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21B and 011A21A) for COVID-19 vaccination. No medical history was reported. The patient's past medical history included Hernia repair hernia surgery.) on 01-Mar-2021. Concomitant products included DIGOXIN (DOGOXINE) for an unknown indication. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced HERNIA REPAIR (hernia surgery after first dose). On an unknown date, the patient experienced VACCINATION SITE WARMTH (hot to the touch), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE PAIN (it started hurting and it was a litlte red) and VACCINATION SITE ERYTHEMA (It is red). On 01-Mar-2021, HERNIA REPAIR (hernia surgery after first dose) outcome was unknown. At the time of the report, VACCINATION SITE WARMTH (hot to the touch), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE PAIN (it started hurting and it was a litlte red) and VACCINATION SITE ERYTHEMA (It is red) outcome was unknown. Concomitant product use also included blood thinners No treatment information was provided Action taken with mRNA-1273 was not applicable

Other Meds: DOGOXINE

Current Illness:

ID: 1601639
Sex: M
Age: 65
State: NJ

Vax Date: 03/02/2021
Onset Date: 03/02/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Mild pain at injection site for 1 1/2 days; This spontaneous case was reported by a health care professional and describes the occurrence of INJECTION SITE PAIN (Mild pain at injection site for 1 1/2 days) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. No Medical History information was reported. On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced INJECTION SITE PAIN (Mild pain at injection site for 1 1/2 days). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE PAIN (Mild pain at injection site for 1 1/2 days) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2021-064258 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-064258:2nd dose case

Other Meds:

Current Illness:

ID: 1601640
Sex: F
Age:
State: NJ

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sweats; low grade fever; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweats), PYREXIA (low grade fever), CHILLS (Chills) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced HYPERHIDROSIS (sweats), PYREXIA (low grade fever), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, HYPERHIDROSIS (sweats), PYREXIA (low grade fever), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. Action taken with mRNA-1273 was not applicable

Other Meds:

Current Illness:

ID: 1601641
Sex: U
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: vials had been punctured more than 6 hours; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of WRONG TECHNIQUE IN DEVICE USAGE PROCESS (vials had been punctured more than 6 hours) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG TECHNIQUE IN DEVICE USAGE PROCESS (vials had been punctured more than 6 hours). At the time of the report, WRONG TECHNIQUE IN DEVICE USAGE PROCESS (vials had been punctured more than 6 hours) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant product use was reported No treatment information was provided

Other Meds:

Current Illness:

ID: 1601642
Sex: F
Age: 78
State: OR

Vax Date: 02/16/2021
Onset Date: 02/24/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: muscle pain/L under shoulder Blade Knife/aching from head to toe like/Get shooting pain and it is on again for 1wk to 2 wk; muscle tight; extreme muscle spasm/Right hip muscle spasm (Knife like)/R Neck /L neck muscle spasm/Knife like; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (extreme muscle spasm/Right hip muscle spasm (Knife like)/R Neck /L neck muscle spasm/Knife like), MYALGIA (muscle pain/L under shoulder Blade Knife/aching from head to toe like/Get shooting pain and it is on again for 1wk to 2 wk) and MUSCLE TIGHTNESS (muscle tight) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy (allergic to codene /stantants) and Colitis in 2004. Concomitant products included VITAMIN C [ASCORBIC ACID], VITAMIN E NOS, CALCIUM, UBIDECARENONE (COQ 10), SALMON OIL, VITAMIN D NOS and MULTI VITAMIN & MINERAL for an unknown indication. On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced MUSCLE SPASMS (extreme muscle spasm/Right hip muscle spasm (Knife like)/R Neck /L neck muscle spasm/Knife like). On 26-Feb-2021, the patient experienced MYALGIA (muscle pain/L under shoulder Blade Knife/aching from head to toe like/Get shooting pain and it is on again for 1wk to 2 wk) and MUSCLE TIGHTNESS (muscle tight). At the time of the report, MUSCLE SPASMS (extreme muscle spasm/Right hip muscle spasm (Knife like)/R Neck /L neck muscle spasm/Knife like), MYALGIA (muscle pain/L under shoulder Blade Knife/aching from head to toe like/Get shooting pain and it is on again for 1wk to 2 wk) and MUSCLE TIGHTNESS (muscle tight) was resolving. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Oxygen saturation: 94 % (normal) 94 and 97 % (normal) 97. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment medications was not provided. Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow-up information received on 14-JUN-2021.Added patient details, medical history, concomitant medications and outcome of the event.

Other Meds: VITAMIN C [ASCORBIC ACID]; VITAMIN E NOS; CALCIUM; COQ 10; SALMON OIL; VITAMIN D NOS; MULTI VITAMIN & MINERAL

Current Illness: Drug allergy (allergic to codene /stantants)

ID: 1601643
Sex: F
Age: 59
State: PA

Vax Date: 03/18/2021
Onset Date: 03/19/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Today at 4am, I had worse headache I have ever had in my entire life. This one wouldn't go away.; I was so nauseated.; arm is sore; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm is sore), CHILLS (chills), PYREXIA (fever), HEADACHE (Today at 4am, I had worse headache I have ever had in my entire life. This one wouldn't go away.) and NAUSEA (I was so nauseated.) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. No Medical History information was reported. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm is sore), CHILLS (chills) and PYREXIA (fever). On 31-Mar-2021, the patient experienced HEADACHE (Today at 4am, I had worse headache I have ever had in my entire life. This one wouldn't go away.) and NAUSEA (I was so nauseated.). On 20-Mar-2021, CHILLS (chills) and PYREXIA (fever) had resolved. On 22-Mar-2021, PAIN IN EXTREMITY (arm is sore) had resolved. On 31-Mar-2021, NAUSEA (I was so nauseated.) had resolved. At the time of the report, HEADACHE (Today at 4am, I had worse headache I have ever had in my entire life. This one wouldn't go away.) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not provided. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow-up received on 07-Jul-2021 included no new information.

Other Meds:

Current Illness:

ID: 1601644
Sex: F
Age:
State: CT

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm turned red from elbow area to her wrist; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm turned red from elbow area to her wrist) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Arm turned red from elbow area to her wrist). At the time of the report, ERYTHEMA (Arm turned red from elbow area to her wrist) outcome was unknown. Not Provided This case was linked to US-MODERNATX, INC.-MOD-2021-064236 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-064236:Second dose

Other Meds:

Current Illness:

ID: 1601645
Sex: F
Age: 62
State: FL

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache; dizziness; sweating on forehead; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), HYPERHIDROSIS (sweating on forehead) and HEADACHE (headache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), METFORMIN, VITAMIN D3, women's multivitamin, FLAXSEED OIL [LINUM USITATISSIMUM SEED OIL], CINNAMOMUM CASSIA BARK, THIOCTIC ACID (CINNAMON ALPHA LIPOIC ACID), MAGNESIUM, OMEPRAZOLE and ATENOLOL for an unknown indication. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced DIZZINESS (dizziness) and HYPERHIDROSIS (sweating on forehead). On 25-Feb-2021, the patient experienced HEADACHE (headache). At the time of the report, DIZZINESS (dizziness), HYPERHIDROSIS (sweating on forehead) and HEADACHE (headache) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. treatment taken was unknown Reporter did not allow further contact

Other Meds: BABY ASPIRIN; METFORMIN; VITAMIN D3; women's multivitamin; FLAXSEED OIL [LINUM USITATISSIMUM SEED OIL]; CINNAMON ALPHA LIPOIC ACID; MAGNESIUM; OMEPRAZOLE; ATENOLOL

Current Illness:

ID: 1601646
Sex: F
Age:
State: NJ

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever of 102; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 102) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PYREXIA (Fever of 102). At the time of the report, PYREXIA (Fever of 102) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not provided

Other Meds:

Current Illness:

ID: 1601647
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain in joints; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (pain in joints) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (pain in joints). At the time of the report, ARTHRALGIA (pain in joints) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No concomitant product use was reported No treatment information was provided Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1601648
Sex: F
Age: 39
State:

Vax Date: 02/21/2021
Onset Date: 02/21/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant) in a 39-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and UNK) for COVID-19 vaccination. No medical history was reported. Concomitant products included IRON FERROUS SULFATE and MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication. On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 28-May-2021. On 21-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnant). On 21-Mar-2021, EXPOSURE DURING PREGNANCY (pregnant) had resolved. Not Provided No treatment information was provided by the reporter.

Other Meds: IRON FERROUS SULFATE; PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]

Current Illness:

ID: 1601649
Sex: F
Age:
State: MO

Vax Date: 03/30/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 103F-104.4F) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. No Medical History information was reported. On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever 103F-104.4F). At the time of the report, PYREXIA (fever 103F-104.4F) outcome was unknown. Not Provided. No concomitant product use was reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1601650
Sex: F
Age: 54
State: MI

Vax Date: 03/08/2021
Onset Date: 03/08/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: low grade fatigue; body pains; fever; felt like she was hit by a truck; DIZZINESS; sweating; blood pressure was low (110/70); heart rate was low; trouble walking; VOMITING; Head was pounding; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt like she was hit by a truck), DIZZINESS (DIZZINESS), HYPERHIDROSIS (sweating), HYPOTENSION (blood pressure was low (110/70)) and HEART RATE DECREASED (heart rate was low) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Asthma. On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced FEELING ABNORMAL (felt like she was hit by a truck), DIZZINESS (DIZZINESS), HYPERHIDROSIS (sweating), HYPOTENSION (blood pressure was low (110/70)), HEART RATE DECREASED (heart rate was low), GAIT DISTURBANCE (trouble walking), VOMITING (VOMITING), HEADACHE (Head was pounding), MYALGIA (body pains) and PYREXIA (fever). On 31-Mar-2021, the patient experienced FATIGUE (low grade fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 15-Mar-2021, FEELING ABNORMAL (felt like she was hit by a truck), DIZZINESS (DIZZINESS), HYPERHIDROSIS (sweating), HYPOTENSION (blood pressure was low (110/70)), HEART RATE DECREASED (heart rate was low), GAIT DISTURBANCE (trouble walking), VOMITING (VOMITING), HEADACHE (Head was pounding), MYALGIA (body pains) and PYREXIA (fever) had resolved. At the time of the report, FATIGUE (low grade fatigue) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: diagnosed APR/2020. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant product use was reported

Other Meds:

Current Illness:

ID: 1601651
Sex: F
Age: 67
State: GA

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sore arm (injection site); This spontaneous case was reported by an other health care professional and describes the occurrence of INJECTION SITE PAIN (sore arm (injection site)) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced INJECTION SITE PAIN (sore arm (injection site)). On 28-Feb-2021, INJECTION SITE PAIN (sore arm (injection site)) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. concomitant product use was not provided. treatment information was not provided This case was linked to US-MODERNATX, INC.-MOD-2021-064269 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-064269:Case created for events after first dose of Moderna Vaccine

Other Meds:

Current Illness:

ID: 1601652
Sex: M
Age: 32
State: TN

Vax Date: 02/09/2021
Onset Date: 03/31/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: he received the 2nd dose outside of the recommended time frame; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (he received the 2nd dose outside of the recommended time frame) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 045A21A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (he received the 2nd dose outside of the recommended time frame). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (he received the 2nd dose outside of the recommended time frame) had resolved. no concomitant medications are reported.

Other Meds:

Current Illness:

ID: 1601653
Sex: F
Age:
State: CT

Vax Date: 02/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: localized erythema; Face with little blotches; Face was puffy; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Face was puffy), ERYTHEMA (localized erythema) and RASH MACULAR (Face with little blotches) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Cancer. In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced SWELLING FACE (Face was puffy) and RASH MACULAR (Face with little blotches). On an unknown date, the patient experienced ERYTHEMA (localized erythema). At the time of the report, SWELLING FACE (Face was puffy) had resolved and ERYTHEMA (localized erythema) and RASH MACULAR (Face with little blotches) outcome was unknown. Not Provided Concomitant product use was not provided by the reporter. No treatment information was provided. The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable. Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded. This case was linked to US-MODERNATX, INC.-MOD-2021-064222 (E2B Linked Report).; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded. US-MODERNATX, INC.-MOD-2021-064222:First dose

Other Meds:

Current Illness: Cancer

ID: 1601654
Sex: F
Age:
State: CA

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: A fever of 100.7; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (A fever of 100.7) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced PYREXIA (A fever of 100.7). At the time of the report, PYREXIA (A fever of 100.7) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.7 (High) fever of 100.7. No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable. The patient's past medical history included No adverse event. On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced PYREXIA (a fever of 100.7). At the time of the report, PYREXIA (a fever of 100.7) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1601655
Sex: M
Age: 55
State: CT

Vax Date: 03/11/2021
Onset Date: 03/11/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; Upset stomach; Redness in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY, ABDOMINAL DISCOMFORT, and VACCINATION SITE ERYTHEMA in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY, ABDOMINAL DISCOMFORT, and VACCINATION SITE ERYTHEMA. At the time of the report, PAIN IN EXTREMITY, ABDOMINAL DISCOMFORT, and VACCINATION SITE ERYTHEMA outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. The patient did not take any treatment medication. This case was linked to MOD-2021-209267.

Other Meds:

Current Illness:

ID: 1601656
Sex: F
Age:
State: NH

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tingling all over her head; Itchy throat; Tingle in her lips as well; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling all over her head), THROAT IRRITATION (Itchy throat) and PARAESTHESIA ORAL (Tingle in her lips as well) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination. No Medical History information was reported. On 30-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PARAESTHESIA (Tingling all over her head), THROAT IRRITATION (Itchy throat) and PARAESTHESIA ORAL (Tingle in her lips as well). At the time of the report, PARAESTHESIA (Tingling all over her head), THROAT IRRITATION (Itchy throat) and PARAESTHESIA ORAL (Tingle in her lips as well) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1601657
Sex: F
Age: 58
State: NJ

Vax Date: 03/30/2021
Onset Date: 03/31/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Body aches; 100.3? F fever; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), PYREXIA (100.3? F fever) and FATIGUE (Tiredness) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PAIN (Body aches), PYREXIA (100.3? F fever) and FATIGUE (Tiredness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Body aches), PYREXIA (100.3? F fever) and FATIGUE (Tiredness) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Mar-2021, Body temperature: 100.3 (High) 100.3? F. No relevant concomitant medications were reported. Action taken with mRNA-1273 in response to the events was not applicable.

Other Meds:

Current Illness:

ID: 1601658
Sex: F
Age: 55
State: NJ

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Can't breath; Back hurts; Cold-like symptoms; Sneezing; Coughing all night long; Back hurts - thinks it's her lungs; Pain more in chest; Chest pressure is worse/ Chest tightness; Blood pressure high; Aches and pain; Felt sick; Dizzy; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY PAIN (Back hurts - thinks it's her lungs), CHEST PAIN (Pain more in chest), CHEST DISCOMFORT (Chest pressure is worse/ Chest tightness), HYPERTENSION (Blood pressure high) and MYALGIA (Aches and pain) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Thyroid disorder (The patient was on medication for thyroid which increases her heart rate - levothyroxine 75 mg.), Allergy (Allergic to just about everything), Asthma (She had major asthma - every time she watched TV she had to turn it off and use her inhaler.) and Borderline diabetes. Concomitant products included ASA and LEVOTHYROXINE for an unknown indication. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced HYPERTENSION (Blood pressure high), MYALGIA (Aches and pain), VACCINATION COMPLICATION (Felt sick), DIZZINESS (Dizzy) and NAUSEA (Nauseous). On 26-Mar-2021, the patient experienced PULMONARY PAIN (Back hurts - thinks it's her lungs), CHEST PAIN (Pain more in chest), CHEST DISCOMFORT (Chest pressure is worse/ Chest tightness) and COUGH (Coughing all night long). On an unknown date, the patient experienced DYSPNOEA (Can't breath), BACK PAIN (Back hurts), NASOPHARYNGITIS (Cold-like symptoms) and SNEEZING (Sneezing). At the time of the report, PULMONARY PAIN (Back hurts - thinks it's her lungs), CHEST PAIN (Pain more in chest), CHEST DISCOMFORT (Chest pressure is worse/ Chest tightness), HYPERTENSION (Blood pressure high), MYALGIA (Aches and pain), VACCINATION COMPLICATION (Felt sick), DYSPNOEA (Can't breath), COUGH (Coughing all night long), BACK PAIN (Back hurts), DIZZINESS (Dizzy), NASOPHARYNGITIS (Cold-like symptoms), SNEEZING (Sneezing) and NAUSEA (Nauseous) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, Blood pressure measurement: high (High) As soon as the shot was administered,her blood pressure was 192/120.. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Other concomitant medications also included inhaler and blood thinner. The patient said that her blood pressure was high before the shot around 130/90 or 140/90.But after the shot it was 179/132.She went to ER on 23-MAR-2021,saw her primary doctor on 24-MAR-2021; Tests were done and was waiting on chest x-ray results. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Follow-up received included additional events (cold-like symptoms and sneezing).

Other Meds: ASA; LEVOTHYROXINE

Current Illness: Allergy (Allergic to just about everything); Asthma (She had major asthma - every time she watched TV she had to turn it off and use her inhaler.); Borderline diabetes; Thyroid disorder (The patient was on medication for thyroid which increases her heart rate - levothyroxine 75 mg.)

ID: 1601659
Sex: F
Age: 60
State: FL

Vax Date: 03/17/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Soreness; Nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness), NAUSEA (Nausea) and FATIGUE (Fatigue) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Soreness), NAUSEA (Nausea) and FATIGUE (Fatigue). At the time of the report, PAIN (Soreness), NAUSEA (Nausea) and FATIGUE (Fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. This case was linked to MOD21-061058 (E2B Linked Report).; Sender's Comments: MOD21-061058:

Other Meds:

Current Illness:

ID: 1601660
Sex: F
Age: 32
State: KS

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant) in a 32-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. Concurrent medical conditions included Nausea. Concomitant products included DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE (BONJESTA) for Nausea, METOPROLOL SUCCINATE (TOPROL) and MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication. On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 04-Aug-2021. On 22-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnant). On 22-Mar-2021, EXPOSURE DURING PREGNANCY (pregnant) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: Toprol; Prenatal Vitamins [Minerals Nos; Vitamins Nos]; Bonjesta

Current Illness: Nausea

ID: 1601661
Sex: F
Age: 82
State: MN

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itch; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itch) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 042L20A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Jan-2021, the patient experienced PRURITUS (Itch). On 28-Jan-2021, PRURITUS (Itch) had resolved. Not Provided mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. Concomitant medication was not provided. Treatment information was not provided. This case was linked to MOD-2021-032567 (Patient Link).

Other Meds:

Current Illness:

ID: 1601662
Sex: F
Age:
State:

Vax Date: 03/28/2021
Onset Date:
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Blood sugars are elevated; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (Blood sugars are elevated) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Co-suspect product included non-company product PROCAINE HYDROCHLORIDE (NOVOCAINE) for an unknown indication. Concurrent medical conditions included Diabetes mellitus (blood sugars are normally well-controlled). On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started PROCAINE HYDROCHLORIDE (NOVOCAINE) (unknown route) at an unspecified dose. On an unknown date, the patient experienced BLOOD GLUCOSE INCREASED (Blood sugars are elevated). At the time of the report, BLOOD GLUCOSE INCREASED (Blood sugars are elevated) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: elevated (High) elevated blood sugars. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided. Reporter did not allow further contact

Other Meds:

Current Illness: Diabetes mellitus (blood sugars are normally well-controlled)

ID: 1601663
Sex: M
Age: 63
State: WI

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Diarrhea; Chills; Body aches; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), CHILLS (Chills), MYALGIA (Body aches) and VOMITING (Vomiting) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The patient's past medical history included COVID-19 in November 2020. On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), CHILLS (Chills), MYALGIA (Body aches) and VOMITING (Vomiting). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea), CHILLS (Chills), MYALGIA (Body aches) and VOMITING (Vomiting) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1601664
Sex: F
Age:
State: TX

Vax Date: 03/11/2021
Onset Date: 03/11/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hot and cold; Swelling in abdomen; Swelling in her abdomen, ankles, and feet; Swelling in her abdomen, ankles, and feet; Exhaustion; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), ABDOMINAL DISTENSION (Swelling in abdomen), JOINT SWELLING (Swelling in her abdomen, ankles, and feet), PERIPHERAL SWELLING (Swelling in her abdomen, ankles, and feet) and FATIGUE (Exhaustion) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Diabetes, Hypertension and Thyroid disorder NOS. On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), ABDOMINAL DISTENSION (Swelling in abdomen), JOINT SWELLING (Swelling in her abdomen, ankles, and feet), PERIPHERAL SWELLING (Swelling in her abdomen, ankles, and feet), FATIGUE (Exhaustion) and CHILLS (Chills). At the time of the report, FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), ABDOMINAL DISTENSION (Swelling in abdomen), JOINT SWELLING (Swelling in her abdomen, ankles, and feet), PERIPHERAL SWELLING (Swelling in her abdomen, ankles, and feet), FATIGUE (Exhaustion) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Relevant concomitant medications included diabetes medication,blood pressure medication and thyroid medication (dose recently increased). No treatment information was provided.

Other Meds:

Current Illness: Diabetes; Hypertension; Thyroid disorder NOS

ID: 1601665
Sex: M
Age:
State:

Vax Date: 03/23/2021
Onset Date: 03/30/2021
Rec V Date: 08/21/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Shoulder got tight; Shoulder got swollen; Where he got the injection is warm; Where he got the injection is itchy; Red dot where he got the injection; Where he got the injection that is swollen; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Shoulder got tight), JOINT SWELLING (Shoulder got swollen), VACCINATION SITE WARMTH (Where he got the injection is warm), VACCINATION SITE PRURITUS (Where he got the injection is itchy) and VACCINATION SITE ERYTHEMA (Red dot where he got the injection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Shoulder got tight), JOINT SWELLING (Shoulder got swollen), VACCINATION SITE WARMTH (Where he got the injection is warm), VACCINATION SITE PRURITUS (Where he got the injection is itchy), VACCINATION SITE ERYTHEMA (Red dot where he got the injection) and VACCINATION SITE SWELLING (Where he got the injection that is swollen). At the time of the report, MUSCULOSKELETAL STIFFNESS (Shoulder got tight), JOINT SWELLING (Shoulder got swollen), VACCINATION SITE WARMTH (Where he got the injection is warm), VACCINATION SITE PRURITUS (Where he got the injection is itchy), VACCINATION SITE ERYTHEMA (Red dot where he got the injection) and VACCINATION SITE SWELLING (Where he got the injection that is swollen) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. Treatment included ice. Reporter did not allow further contact

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 03 October 2021 5:28pm